Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIR
3051
DELISTED
CIRCOR International, Inc
CIR
| $659K | ﹤0.01% |
24,216
+7,526
| +45% | +$229K |
|
|
TPIC
3052
DELISTED
TPI Composites
TPIC
| $658K | ﹤0.01% |
43,991
+28,173
| +178% | +$691K |
|
3053
Phibro Animal Health
PAHC
$1.47B
| $657K | ﹤0.01% |
32,230
+10,709
| +50% | +$229K |
|
3054
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $653K | ﹤0.01% |
55,534
-21,026
| -27% | -$258K |
|
3055
Ribbon Communications
RBBN
$377M
| $653K | ﹤0.01% |
107,794
+64,433
| +149% | +$382K |
|
3056
Tecnoglass Holdings Inc.
TGLS
$1.93B
| $651K | ﹤0.01% |
24,841
+13,928
| +128% | +$390K |
|
3057
iRadimed
IRMD
$1.16B
| $650K | ﹤0.01% |
14,079
+5,104
| +57% | +$206K |
|
3058
OneSpaWorld
OSW
$2.61B
| $650K | ﹤0.01% |
64,942
+43,340
| +201% | +$460K |
|
3059
Seneca Foods Class A
SENEA
$1.12B
| $650K | ﹤0.01% |
13,545
+2,939
| +28% | +$145K |
|
3060
Nature's Sunshine
NATR
$354M
| $649K | ﹤0.01% |
35,115
+9,548
| +37% | +$162K |
|
|
TBCH
3061
Turtle Beach Corp
TBCH
$243M
| $647K | ﹤0.01% |
29,110
+22,900
| +369% | +$618K |
|
3062
MasterCraft Boat Holdings
MCFT
$579M
| $646K | ﹤0.01% |
22,822
+5,039
| +28% | +$138K |
|
3063
Luxfer Holdings
LXFR
$456M
| $645K | ﹤0.01% |
33,445
+21,281
| +175% | +$433K |
|
3064
Vanguard Financials ETF
VFH
$13.5B
| $645K | ﹤0.01% |
6,680
-26,050
| -80% | -$2.54M |
|
3065
PUT
Universal Display
OLED
$3.68B
| $644K | ﹤0.01% |
3,900
| – | – |
|
3066
Akebia Therapeutics
AKBA
$354M
| $643K | ﹤0.01% |
284,770
+96,413
| +51% | +$263K |
|
3067
Inseego
INSG
$114M
| $643K | ﹤0.01% |
11,028
+7,198
| +188% | +$468K |
|
3068
The RMR Group
RMR
$325M
| $642K | ﹤0.01% |
18,523
+11,390
| +160% | +$395K |
|
|
IDEX
3069
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $640K | ﹤0.01% |
4,269
+2,912
| +215% | +$621K |
|
3070
PUT
Transocean
RIG
$5.89B
| $639K | ﹤0.01% |
231,700
| – | – |
|
3071
Omeros
OMER
$857M
| $637K | ﹤0.01% |
99,216
+61,698
| +164% | +$447K |
|
3072
CALL
Walmart Inc
WMT
$885B
| $637K | ﹤0.01% |
13,200
-195,300
| -94% | -$9.32M |
|
|
KE
3073
Kimball Electronics
KE
$595M
| $636K | ﹤0.01% |
29,220
+19,382
| +197% | +$486K |
|
3074
Modine Manufacturing
MOD
$10.7B
| $636K | ﹤0.01% |
63,000
+41,703
| +196% | +$464K |
|
3075
MetroCity Bankshares
MCBS
$1.01B
| $635K | ﹤0.01% |
23,049
+15,289
| +197% | +$389K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.